Cytokeratin 8/18 (B22.1 & B23.1), MMab
Research literature shows that CK8/18 is expressed in simple or glandular epithelium in tumors or normaltissues, such as thyroid, breast, gastrointestinal tract, and respiratory epithelium. It is expressed in adenocarcinoma and most non-keratin izing squamous cell carcinomas, but not in keratin izing squamous cell carcinomas. Therefore, this antibody is usually used in combination with CK5/6 for the differential diagnosis of adenocarcinoma and squamous cell carcinoma.
Intended Use
Research literature shows that CK8/18 is expressed in simple or glandular epithelium in tumors or normaltissues, such as thyroid, breast, gastrointestinal tract, and respiratory epithelium. It is expressed in adenocarcinoma and most non-keratin izing squamous cell carcinomas, but not in keratin izing squamous cell carcinomas. Therefore, this antibody is usually used in combination with CK5/6 for the differential diagnosis of adenocarcinoma and squamous cell carcinoma.
Storage & Validity
Store at 2~8°C. Avoid freezing.
Maintain temperature below room temperature during transport, ensuring it does not exceed one week.
Specifications
| Product Name | Cytokeratin 8/18 (B22.1 & B23.1), MMab |
| Clone | B22.1 & B23.1 |
| Catalog No. | CCM-1011 |
| Positive Site | Cytoplasm |
| Applicable Tissue | Paraffin section |
| Pre-treatment | Heat retrieval |
| Format and Volume | Ready-to-use: 1mL, 3mL, 6mL Concentrated: 0.1mL, 0.2mL, 1mL |
Download
-
Intended Use
-
Specifications
Related Product
